Hi! I sent you a FB message about it and how it makes complete sense especially for primary tumors that respond to chemotherapy or chemoradiation.

The drugs are proven and widely used in conventional treatment. So, there isn't anything dicey about what therapy they would prescribe. They are just going about the diagnostic process in a more logical and focused way.

It will keep from wasting time on something that doesn't work. And they offer the possibility of testing people for genetic factors that influence efficacy. That would be a huge benefit--especially for people who suffer through weeks of something like Erbitux only to find out it didn't work.

I see a new standard of care on the horizon. If it works, then it will save money and collateral damage in lives saved and unnecessary morbidity after failed treatment. Wow!